Stockreport

Myomo outlines 10% revenue growth target for 2026 while expanding recurring patient sources and international operations [Seeking Alpha]

Myomo Inc.  (MYO) 
NASDAQ:AMEX Investor Relations: myomo.com/investor-opportunities
PDF Paul Gudonis, President, CEO & Chairman, highlighted progress on four major objectives: growing revenue through direct-to-patient marketing and recurring sources, expan [Read more]